Tofacitinib citrate (CAGE Bio)

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameTofacitinib citrate (CAGE Bio)
Drug Alias Name1% TofacitinibCGB-500CGB-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase JAK2 inhibitorsTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2Tyrosine-protein kinase JAK3
Therapy Area/IndicationsAlopecia AreataDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGeorgia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCAGE Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesCAGE Bio Inc
Inactive CompaniesN/A
Active IndicationsAlopecia AreataDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A